Stock Rating Downgrade
The Value Trend Rating for Axsome Therapeutics Inc (NASDAQ: AXSM) weakened recently from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our next report.
Recent Price Action
Axsome Therapeutics Inc (NASDAQ: AXSM) stock closed at $80.05 on 1/10/25 after a decline of -3.1%. Moreover, trading volume in this decline was unusually high at 177% of normal. The stock has declined -5.4% during the last week but has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Axsome Therapeutics has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects very contradictory signals from PTR's two proprietary measures of a stock's attractiveness. Axsome Therapeutics has a very low Appreciation Score of 6 but a good Power Rating of 72, triggering the Negative Value Trend Rating.